Published in PLoS One on August 01, 2007
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med (2008) 5.81
Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One (2010) 1.88
Humanized mouse models of HIV infection. AIDS Rev (2011) 1.49
The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology (2009) 1.42
Novel humanized murine models for HIV research. Curr HIV/AIDS Rep (2009) 1.40
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. AIDS (2012) 1.32
Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice. J Infect Dis (2012) 1.23
Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1. PLoS One (2012) 1.12
IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo. PLoS Pathog (2010) 1.11
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells. Int J Nanomedicine (2012) 1.08
Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice. PLoS One (2007) 1.06
Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice. J Biol Chem (2008) 1.05
Can the new humanized mouse model give HIV research a boost. PLoS Med (2008) 1.04
New insights into HIV-1-primary skin disorders. J Int AIDS Soc (2011) 1.03
HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol (2012) 1.03
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages. J Infect Dis (2012) 0.96
Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis. Sci China Life Sci (2010) 0.94
Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque. Antimicrob Agents Chemother (2015) 0.88
Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection. Chem Biol (2015) 0.80
Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice. Virology (2014) 0.78
Summary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop. AIDS Res Ther (2008) 0.78
Preexposure prophylaxis with albumin-conjugated C34 peptide HIV-1 fusion inhibitor in SCID-hu Thy/Liv mice. Antimicrob Agents Chemother (2012) 0.77
Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies. Biologicals (2011) 0.75
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection. Mol Pharmacol (2017) 0.75
In Vivo validation of a bioinformatics based tool to identify reduced replication capacity in HIV-1. Open Med Inform J (2010) 0.75
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice. PLoS One (2017) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (1988) 9.05
Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep (1966) 8.79
Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J Virol (1998) 4.48
Infection of the SCID-hu mouse by HIV-1. Science (1988) 4.37
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet (2005) 4.21
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med (2007) 3.75
HIV induces thymus depletion in vivo. Nature (1993) 3.73
Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med (1990) 3.59
The SCID-hu mouse as a model for HIV-1 infection. Nature (1993) 3.43
Antiviral drugs in current clinical use. J Clin Virol (2004) 3.23
Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci U S A (2006) 3.07
Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med (1993) 2.81
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity (2007) 2.45
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1995) 2.39
Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol (2006) 2.24
HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology (2006) 2.17
Resistance to enfuvirtide, the first HIV fusion inhibitor. J Antimicrob Chemother (2004) 2.14
HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood (2007) 2.10
HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity (1995) 2.07
Suppression of HIV infection in AZT-treated SCID-hu mice. Science (1990) 1.97
CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J Virol (1997) 1.88
Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol (1994) 1.87
Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol (1996) 1.80
Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci (1986) 1.80
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol (1998) 1.72
Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J Immunol (1991) 1.65
CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J Immunol (1998) 1.64
The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol (1991) 1.63
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother (1996) 1.54
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother (1996) 1.51
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents. Antimicrob Agents Chemother (2000) 1.26
In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J Virol (1995) 1.24
Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nat Med (1997) 1.21
Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc Natl Acad Sci U S A (1991) 1.21
IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J Immunol (2002) 1.19
Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J Virol (2003) 1.11
Regions of human immunodeficiency virus type 1 nef required for function in vivo. J Virol (1998) 1.09
High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J Virol (1997) 1.09
Development and applications of the SCID-hu mouse model. Semin Immunol (1996) 1.05
Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo. J Virol (1998) 1.04
Animal models of HIV-1 disease. Science (1997) 1.04
Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms. J Immunol (1999) 1.03
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice. Antimicrob Agents Chemother (2000) 1.03
Identification of HIV-1 determinants for replication in vivo. Virology (1997) 1.02
Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP. FASEB J (1999) 1.00
Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus. AIDS Res Hum Retroviruses (2000) 0.98
Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy. J Virol (1999) 0.90
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus. J Virol (1999) 0.90
Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1. J Virol (1997) 0.87
Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320. Antimicrob Agents Chemother (1998) 0.85
HIV type 1 infection in lymphoid tissue: natural history and model systems. AIDS Res Hum Retroviruses (1998) 0.79
Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science (2010) 4.22
Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice. Virology (2011) 1.23
IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J Immunol (2002) 1.19
Expanding the Hoogsteen edge of 2'-deoxyguanosine: consequences for G-quadruplex formation. Org Lett (2004) 1.18
Isostructural self-assembly of 2'-deoxyguanosine derivatives in aqueous and organic media. J Am Chem Soc (2008) 1.17
Hexadecameric self-assembled dendrimers built from 2'-deoxyguanosine derivatives. Org Lett (2008) 1.16
Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J Virol (2003) 1.11
Solvent-induced high fidelity switching between two discrete supramolecules. J Am Chem Soc (2009) 1.07
Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice. PLoS One (2007) 1.06
Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice. J Biol Chem (2008) 1.05
Nonpolymeric thermosensitive supramolecules. J Am Chem Soc (2009) 1.05
Walking a supramolecular tightrope: a self-assembled dodecamer from an 8-aryl-2'-deoxyguanosine derivative. J Am Chem Soc (2009) 1.02
Drug encapsulation within self-assembled microglobules formed by thermoresponsive supramolecules. Chem Commun (Camb) (2010) 0.89
Aquatic self-assembly of sixteen subunits into a 39-kDa dendrimer. Langmuir (2010) 0.89
Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? Cancer Lett (2006) 0.84
Metallo-responsive switching between hexadecameric and octameric supramolecular G-quadruplexes. Chem Commun (Camb) (2011) 0.82
Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target. Curr Med Chem (2004) 0.82
Synthesis of 8-Heteroaryl-2'-deoxyguanosine Derivatives. Synlett (2008) 0.82
Self-assembled cation transporters made from lipophilic 8-phenyl-2'-deoxyguanosine derivatives. Supramol Chem (2010) 0.79
Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores. Virology (2012) 0.78
Preexposure prophylaxis with albumin-conjugated C34 peptide HIV-1 fusion inhibitor in SCID-hu Thy/Liv mice. Antimicrob Agents Chemother (2012) 0.77
Patchy supramolecules as versatile tools to probe hydrophobicity in nanoglobular systems. J Am Chem Soc (2013) 0.77
Elevated caspase-3 expression and T-cell activation in elite suppressors. J Acquir Immune Defic Syndr (2010) 0.76
Tuning thermoresponsive supramolecular G-quadruplexes. Langmuir (2015) 0.75
The impact of 8-aryl-and 8-heteroaryl-2'-deoxyguanosine derivatives on G-quadruplex formation. Nucleic Acids Symp Ser (Oxf) (2007) 0.75
A series of C-terminal amino alcohol dipeptide A beta inhibitors. Bioorg Med Chem Lett (2002) 0.75
Assessing aging stereotypes: Personal stereotypes, self-stereotypes and self-perception of aging. Psicothema (2017) 0.75